Alio


Developer of a remote patient monitoring platform based on a non-invasive, multi-metric wearable patch, hub, and cloud portal. The platform provides continuous, non‑blood-based monitoring of electrolytes and clinical-grade vitals for ambulatory and dialysis patients, with FDA clearance and features for clinic-level population management and automated notifications.

Industries

Analytics
Health Care
Health Diagnostics
Medical
Real Time
Wearables
mHealth
Medical Equipment Manufacturing

Nr. of Employees

small (1-50)

Alio

Broomfield, Colorado, United States


Patents

Method and apparatus for measuring flow through a lumen

US-12064259-B2

View Details

Systems and methods for measuring biological metrics and blood vessel geometry using a multiple optical path photoplethysmography device

US-11937906-B2

View Details

System and method for detecting a periprosthetic infection

US-11898961-B2

View Details

Method and apparatus for measuring flow through a lumen

US-11547352-B2

View Details

Wearable device with multimodal diagnostics

US-11045123-B2

View Details

System and method for measuring blood flow parameters in a blood vessel having an endovascular prosthesis

US-11006845-B2

View Details
View All Patents

Products

Multi-metric wearable monitoring system (patch, hub, portal)

Integrated system composed of a wearable patch sensor, a hub device for data relay, and a cloud portal that provides continuous, non‑invasive monitoring of electrolytes and vital signs without blood draws.


Services

Cloud-hosted platform that aggregates continuous data from wearable sensors, provides clinician dashboards and automated notifications for proactive care.

Expertise Areas

  • Remote patient monitoring
  • Non-invasive biosensing
  • Dialysis and chronic kidney disease monitoring
  • Digital health platform development
  • Show More (3)

Key Technologies

  • Wearable sensor patch
  • Non-invasive electrolyte monitoring
  • Continuous vital-sign sensing
  • Auscultation sensors (audio-based physiological monitoring)
  • Show More (4)

News & Updates

Blog post summarizing recent clinical studies demonstrating the platform's monitoring capabilities in CKD and related conditions.

Blog post summarizing company developments from 2023.

Press release announcing a Series C financing first close.

Homepage states the platform is FDA-cleared for multiple monitored metrics.

Site references a HIPAA Seal of Compliance verification.

Site lists multiple awards and recognitions (including prize mentions) related to the platform and company.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.